The company has plenty of cash and far too much idle capacity. Looks like this offering is an attempt to grab money for future use, but what? And at what price? I suspect the shorts feel a lot better about their positions with this news.
September 22nd, 2013/BUSINESSWIRE - Today, Mevion Medical Systems announced moving from acceptance testing to the clinical commissioning phase of its MEVION S250 Proton Therapy System installed at the S. Lee Kling Center for Proton Therapy at the Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, MO.
..."We are excited to be in final clinical preparation for our first patient treatment later this year," added Jeffrey D. Bradley, MD, Washington University radiation oncologist and director of the S. Lee Kling Center for Proton Therapy.
* Looks like at least 5 centers will be operational by this time next year. Payments to TechPrecision should vastly improve the financial conditions and the refinancing under better terms should be completed. Will also be nice to have some payments in the bank from the sapphire furnaces contract. 2014 is looking like a very good turnaround story.
The sapphire furnace contract(s) are an incredibly well timed bridge to very promising projects that have been slow to come to full fruition. If you trust management you have found a company that hit a series of bad luck/poor timing contracts on top of an expected sudden freezing up of their furnace contracts.
If this turnaround works it will pay huge returns for investors getting in at the bottom. It's all about trusting management to value shareholders. If management can pull off a turnaround it will be an investment few can equal.
Sapphire, 1914 is going to be the year of big expansion is uses. I'm guessing
users are busy locking up sapphire sources for next few years.
Looks like a erfect storm brewnging for the patient.
Short % of Float (as of Oct 31, 2013)3: 39.80%
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,909,093 shares of common stock, consisting of shares beneficially owned by MFS and/or certain other non-reporting entities.
Previous holding reported:
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 09/30/2013 2,061,273
900,000 shares not available to a massive short position. Wonder who Rubicon is in talks with to take advantage of the suddenly holt market of expanded sapphire production.
Buy the dips in what may be the top stock by the end of 2014,
GLTA the small traders short. Just wondering what the short logic is as 2014 sapphire demand unfolds. Please no bashing, an honest rebuttal please that keeps you short?
Seamark International says:
.....With more than a million installations around the world, it is easy to see why Seamark sapphire scanner assemblies lead the way in customer satisfaction. While sapphire scanner windows have been around since the mid seventies, they have been gaining considerable acceptance at retailers of all sizes who have tested this option and analyzed the results. The long-term economic benefits of using sapphire scanner windows are clear to see.
It's going far beyond mobile phones. Military is testing a 2 inch thick small window according to Rubicon. Just returned to the US and used an all finger (four fingers) scan for quick entry. Anyone else think Apple has seen the future and sapphire was a much bigger role to play?
Nice move today, on high volume.
Maybe some internal PharAthene programs are getting some interest that will be revealed in the new year? PharmAthene management was not happy with the response Theraclone's candidate was treated. Guessing it likes the feedback it sees on it's own projects much more in comparison.
Bye, Bye Theraclone. What was that tryst all about?
ROI for the shareholder, please. After 10 years it's time for shareholders to see a return on their investment via the cash coming to Pharmathene. Theraclone adds another 10 years out, big maybe, before investors will see anything on their investment.
Looks like a grab by MPM with no concern for the small shareholders.
Thanks for the insight. Also see it as some very good chances as the start of a turnaround. RAD is a good example of what kind of return you can get once a turnaround gains traction. An older one I had was KKD, it took a couple of years but has recently gone huge to the upside. I've got patience and just need to see solid financials to get the nerve to hand on long term. If management proves shareholder friendly this on could be the best of all IF things go well.
Today, looks like traders are trying to unload some shares and old timers want them cheap, sub .60 today. Feels like a bottom as I don't see many shares being unloaded.
Spill the beans johnnie. If you were new to this one with plans to build a position in the stock would you:
Wait for pullbacks.
Wait for news and pay the piper
Buy your full position now as then news coming from GT & Apple has lit the fuse.
So far, waiting for pullbacks been a miserable loss. However, I am patient if I think the short term will bring dips, I'll gladly wait.
Appreciate all opinions
Looked it up on YouTube and the stuff is impossible to scratch. Bring the price down by using a coating in large applications may reopen uses to applications considered to expensive as an alternative in the past.
2014 - 2015 is going to be good time to be a sapphire producer, again.
Sapphire use was expected to greatly expand in 2014 and 2015 regardless. The use of sapphire in phones and tablets could dwarf LLED lighting. Doesn't someone want to lock up Rubicon's production potential before the real world becomes more aware of the coming demand/supply situation Apple sees?
A lot of information on the seeking alpha transcript. Hard to believe the Apple/GTAT order comes in with an $8 million ASAP order when it was so badly needed. I'll take be lucky over smart any day.
I would have no issue with 1 million shares at $2 sometimes soon, takes money to make money.
Peter Trapp - Bifrost Fund
Yes, hi Rich. Now I’ve got a couple of observations, because I did quite a bit of check and I’m sure your aware that this Apple order, Apple their commitment to try to do more business or manufacture more in the United States and they are going to provide financing to GT for the product that they are going to be building and I’m wondering if there is no chance, at least as your short of cash or you’d like to get your hands on some cash, there wouldn’t be a trickle down effect that if Apple is going to fund GT, why shouldn’t GT take some of that money and help fund you on this order or pre fund it?
Leonard Anthony - Chairman & Principal Executive Officer
Yes, no I would say that we have good terms and conditions on this order relative to cash.
****my take. the GTAT order is ASAP. Don't think Apple would let GTAT deal with a supplier that didn't have some financing in the works to ensure no interruptions in what has become a high profile sapphire project.
Don't tell anyone, please. I love the way this one is pulling back as I add more shares for a very promising 2014. My dream , pick up some shares in the 50 cent range.
A buyback at below book value is a no brainer. Management could do a sizable buyback AND give a handsome dividend. Is there anything they would be interested in buying that offers the value of a buyback? No.
GLTA, looks like an end of year buying opportunity. I'll be shocked if the sales prices stays for long.